Recent Press Releases

Transgene and ABL Announce the Acquisition by ABL Europe of Transgene's Production Asset

STRASBOURG, France & ROCKVILLE, Md.--()--Transgene SA (Euronext: TNG) a company specializing in immunotherapies, and ABL, Inc., a contract research and manufacturing organization,...

Introducing a Better Way to Manage Drug Development

SILVER SPRING, Md.--()--Aurotech Inc. announces the launch of the Drug Lifecycle Tracking Application(DLTA). Through DLTA, Aurotech helps companies simplify work and process management...

Patheon Appoints Leader for Biologics

DURHAM, N.C.--()--Patheon today announced the appointment of Steve Lam as senior vice president of the company's biologics business. Lam will report to Lukas Utiger, president of...

Novasep adds synthesis and kilo lab extensions to US facility

Enhanced capabilities bring Novasep's unique range of specialized drug development technologies within easier reach of North American customers Lyon, France, January 28, 2016 – Novasep,...

Evotec Awarded Grant from The Michael J. Fox Foundation for Parkinson's Research

HAMBURG, Germany--()--Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced that it has been awarded a research grant from The Michael J. Fox Foundation...

Catalent Invests $4.6M To Further Expand Asia–Pacific Clinical Trials Hub In Singapore

Somerset, N.J., – February 2, 2016 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer...

Facility expansion at CRO following record year

ONYX Scientific is set to increase the size of its UK-based site by over 30pc following the best performance in the company's 15 year history. The contract research organisation (CRO) and...

Bioclinica Announces Post-Approval Research Service

Deep experience and operational excellence offer an alternate way to conduct post-marketing studiess Bioclinica®, a specialty clinical trials services and technology provider, announced...

Amatsigroup acquires Q-Biologicals and strengthens its offering for international pharmaceutical groups

Amatsigroup acquires Q-Biologicals and strengthens its offering for international pharmaceutical groups Q-Biologicals, a leading-edge provider of process development and biomanufacturing services ...

ICON Releases Flex Advantage to Enhance Patient Randomisation and Clinical Supply Management in Clinical Trials

New technology platform reaffirms ICON as the CRO industry's pre-eminent provider of adaptive clinical trial services Dublin, Ireland, 19th January, 2015 – ICON plc, (NASDAQ: ICLR) a...

PAREXEL International Reports Second Quarter Fiscal Year 2016 Results

Adjusted earnings per share of $0.90, up 30.4%; GAAP diluted earnings per share of $0.73 Adjusted operating margin of 13.2%; GAAP operating margin of 10.5% Gross new business wins of $867...

Bioclinica Provides Risk-Based Monitoring Solution in Japan

Bioclinica Provides Risk-Based Monitoring Solution in Japan EPS to Run Clinical Studies Using COMPASS DOYLESTOWN, Pa., Jan. 25, 2016 /PRNewswire/ -- Bioclinica®, Inc., a specialty clinical trials...

Optum and PAREXEL to Accelerate Drug Development, Reimbursement and Market Access with EHR-Fueled Clinical Research and Hybrid Studies

Collaboration will focus on advancing drug development by combining clinical research and real-world evidence BOSTON and WAKEFIELD, Mass., Jan. 21, 2016– Optum and PAREXEL International...

Bioclinica Announces Post-Approval Research Service

Deep experience and operational excellence offer an alternate way to conduct post-marketing studies. Bioclinica®, a specialty clinical trials services and technology provider, announced...

Celltrion and Medidata Team Up to Transform Global Clinical Trials for Biosimilars

NEW YORK & SEOUL, Korea--()--Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, and Korean biopharmaceutical...

Catalent To Open New Clinical Supply Facility In Japan

Somerset, N.J., — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health products and global...

PAREXEL Announces Execution of Definitive Agreement to Acquire Health Advances

Acquisition will strengthen PAREXEL's Leadership in Strategic Consulting Services BOSTON, January 19, 2016 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global...

Leading Provider Expands into Financial Management Solutions for Clinical Trials

Bioclinica®, Inc., a specialty clinical trials services and technology provider, announced today that it has acquired Clinverse, Inc. The acquisition expands Bioclinica's offerings into the...

New Clinic in Miami Extends inVentiv Health Phase I Services to the U.S.

MIAMI, Jan. 12, 2016 /PRNewswire/ -- inVentiv Health, a top-tier professional services organization that accelerates the clinical and commercial success of biopharmaceutical companies worldwide,...